FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3001686135> ?p ?o ?g. }

• W3001686135 endingPage "204" @default.
• W3001686135 startingPage "194" @default.
• W3001686135 abstract "Several reports demonstrated that rifampicin affected pharmacokinetics of victim drugs following oral more than intravenous administration. We aimed to establish a semi-physiologically based pharmacokinetic (semi-PBPK) model involving both enzyme and transporter turnover to simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 (CYP) 3A4/P‑glycoprotein (P-GP) in human. Rifampicin was chosen as the CYP3A /P-GP inducer. Thirteen victim drugs including P-GP substrates (digoxin and talinolol), CYP3A substrates (alfentanil, midazolam, nifedipine, ondansetron and oxycodone), dual substrates of CYP3A/P-GP (quinidine, cyclosporine A, tacrolimus and verapamil) and complex substrates (S-ketamine and tramadol) were chosen to investigate drug-drug interactions (DDIs) with rifampicin. Corresponding parameters were cited from literatures. Before and after multi-dose of oral rifampicin, the pharmacokinetic profiles of victim drugs for oral or intravenous administration to human were predicted using the semi-PBPK model and compared with the observed values. Contribution of both CYP3A and P-GP induction in intestine and liver by rifampicin to pharmacokinetic profiles of victim drugs was investigated. The predicted pharmacokinetic profiles of drugs before and after rifampicin administration accorded with the observations. The predicted pharmacokinetic parameters and DDIs were successful, whose fold-errors were within 2. It was consistent with observations that the DDIs of rifampicin with oral victim drugs were larger than those with intravenous victim drugs. DDIs of rifampicin with CYP3A or P-GP substrates following oral versus intravenous administration to human were successfully predicted using the developed semi-PBPK model." @default.
• W3001686135 created "2020-01-30" @default.
• W3001686135 creator A5000665985 @default.
• W3001686135 creator A5020819058 @default.
• W3001686135 creator A5063481044 @default.
• W3001686135 creator A5071484261 @default.
• W3001686135 creator A5084944295 @default.
• W3001686135 date "2019-06-01" @default.
• W3001686135 modified "2023-10-12" @default.
• W3001686135 title "Simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 3A/P‑glycoprotein to healthy human using a semi-physiologically based pharmacokinetic model involving both enzyme and transporter turnover" @default.
• W3001686135 cites W152943885 @default.
• W3001686135 cites W1560709301 @default.
• W3001686135 cites W1593274271 @default.
• W3001686135 cites W1905936368 @default.
• W3001686135 cites W1975760985 @default.
• W3001686135 cites W1979732900 @default.
• W3001686135 cites W1983931738 @default.
• W3001686135 cites W1984755508 @default.
• W3001686135 cites W1985697220 @default.
• W3001686135 cites W1987424786 @default.
• W3001686135 cites W1987913034 @default.
• W3001686135 cites W1987952101 @default.
• W3001686135 cites W1991992414 @default.
• W3001686135 cites W1995804845 @default.
• W3001686135 cites W1996086250 @default.
• W3001686135 cites W1997211783 @default.
• W3001686135 cites W2005328285 @default.
• W3001686135 cites W2022545732 @default.
• W3001686135 cites W2027292745 @default.
• W3001686135 cites W2028568752 @default.
• W3001686135 cites W2029590089 @default.
• W3001686135 cites W2034467767 @default.
• W3001686135 cites W2035268683 @default.
• W3001686135 cites W2036485697 @default.
• W3001686135 cites W2040743079 @default.
• W3001686135 cites W2040944040 @default.
• W3001686135 cites W2046948630 @default.
• W3001686135 cites W2050109686 @default.
• W3001686135 cites W2055553642 @default.
• W3001686135 cites W2056872819 @default.
• W3001686135 cites W2059588998 @default.
• W3001686135 cites W2067078906 @default.
• W3001686135 cites W2068994423 @default.
• W3001686135 cites W2072055545 @default.
• W3001686135 cites W2073747956 @default.
• W3001686135 cites W2075326549 @default.
• W3001686135 cites W2079436617 @default.
• W3001686135 cites W2088125097 @default.
• W3001686135 cites W2090772210 @default.
• W3001686135 cites W2097548732 @default.
• W3001686135 cites W2107001433 @default.
• W3001686135 cites W2111668019 @default.
• W3001686135 cites W2117927958 @default.
• W3001686135 cites W2121460361 @default.
• W3001686135 cites W2127059331 @default.
• W3001686135 cites W2142573506 @default.
• W3001686135 cites W2144062256 @default.
• W3001686135 cites W2146591007 @default.
• W3001686135 cites W2147757531 @default.
• W3001686135 cites W2161894198 @default.
• W3001686135 cites W2255376174 @default.
• W3001686135 cites W2322548405 @default.
• W3001686135 cites W2761233380 @default.
• W3001686135 cites W2885634736 @default.
• W3001686135 cites W2909560874 @default.
• W3001686135 cites W2917528631 @default.
• W3001686135 cites W4323284006 @default.
• W3001686135 doi "https://doi.org/10.1016/j.ejps.2019.04.026" @default.
• W3001686135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31047967" @default.
• W3001686135 hasPublicationYear "2019" @default.
• W3001686135 type Work @default.
• W3001686135 sameAs 3001686135 @default.
• W3001686135 citedByCount "17" @default.
• W3001686135 countsByYear W30016861352020 @default.
• W3001686135 countsByYear W30016861352021 @default.
• W3001686135 countsByYear W30016861352022 @default.
• W3001686135 countsByYear W30016861352023 @default.
• W3001686135 crossrefType "journal-article" @default.
• W3001686135 hasAuthorship W3001686135A5000665985 @default.
• W3001686135 hasAuthorship W3001686135A5020819058 @default.
• W3001686135 hasAuthorship W3001686135A5063481044 @default.
• W3001686135 hasAuthorship W3001686135A5071484261 @default.
• W3001686135 hasAuthorship W3001686135A5084944295 @default.
• W3001686135 hasConcept C112705442 @default.
• W3001686135 hasConcept C11824378 @default.
• W3001686135 hasConcept C126322002 @default.
• W3001686135 hasConcept C133936738 @default.
• W3001686135 hasConcept C142462285 @default.
• W3001686135 hasConcept C185592680 @default.
• W3001686135 hasConcept C185867374 @default.
• W3001686135 hasConcept C203014093 @default.
• W3001686135 hasConcept C2777056448 @default.
• W3001686135 hasConcept C2778607973 @default.
• W3001686135 hasConcept C2778707650 @default.
• W3001686135 hasConcept C2781432083 @default.
• W3001686135 hasConcept C2993143319 @default.
• W3001686135 hasConcept C3013748606 @default.
• W3001686135 hasConcept C501593827 @default.

• next